Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its structure supports the creation of chiral building blocks for drug candidates, enhancing metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties due to the presence of the trifluoromethyl group, which improves lipophilicity and resistance to oxidative degradation. Also utilized in the preparation of enzyme inhibitors and receptor modulators, especially in projects involving fluorinated analogs for improved efficacy and selectivity.